Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Basal Cell Carcinoma of the Head and Neck × Tissue Banks × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1 Skin Neoplasms 1 Neoplasm Metastasis 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Basal Cell Carcinoma of the Head and Neck 1

Interventions

pembrolizumab 1 Tissue Banks 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04323202 2025-10-24

Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N

Case Comprehensive Cancer Center

Phase 1 Completed

DermatologicHead & Neck

Basal Cell Carcinoma of the Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡